Teva

The curse of being Israel's most valuable company

Tower's share price has jumped nearly 900% in the past five years, but less than 24 hours after reaching the top, the world's chip stocks plummeted, and Tower's share price tumbled 10.79%

In January, Israel’s Ministry of Defense signed a multi-year contract with Semiconductor Devices valued at approximately $115 million (NIS 380 million).
The logistics center of Teva Pharmaceutical Industries in Shoham

Mega deal: Teva acquires Emalex for approximately $900 million

Noam Zilbershtain, senior vice president and general manager, HP Indigo; Adi Soffer Teeni, CEO of Meta Israel, vice president and member of the EMEA leadership team; and Karin Mayer Rubinstein, CEO and president of IATI.

IATI CEOs Forum meets in Kiryat Gat to discuss multinational industry resilience

Amalia Adler-Waxman, Iris Gilboa, Yael Ashman, receiving the Keshet award for promoting gender equality in corporations, presented by Ilan Flato and Anat Pilzer-Somech at the Tel Aviv Stock Exchange.

Teva honored for gender equality as women reach 43% of senior management in Israel


Israeli Teva reaches proposed $4.35 bln settlement of US opioid lawsuits

The US opioid crisis has caused more than 500,000 overdose deaths over the past two decades, including more than 80,000 in 2021 alone.

 Teva building in Kfar Saba

Grapevine: Screaming sumo

Movers and shakers in Israeli society.

 Teva building in Kfar Saba

Teva, Allergan reach $161.5 million opioid settlement with West Virginia

The agreement is the largest state-negotiated settlement in West Virginia history and consists of $134 million in cash plus the contribution of drugs used to treat opioid overdoses.

A building belonging to generic drug producer Teva, Israel's largest company with a market value of about $57 billion, is seen in Jerusalem

State sues Teva over Copaxone drug royalties

Two doctors sued Teva for failing to acknowledge their contributions and demanded to be compensated with royalties stemming from the new version of copaxone.

Teva CEO Kåre Schultz at the Tel Aviv Stock Exchange, February 19, 2020

Ukrainian refugees offered free medical services in Israel

Many of them are not Jewish and are therefore ineligible for access to universal healthcare in Israel.

 Ukraine refugees wait at stations close to the border

Rhode Island takes Teva to trial in multibillion-dollar opioid case

The multibillion-dollar trial will determine whether the Israeli company contributed to an opioid crisis that has caused more than 500,000 deaths over the past two decades.

 Teva building in Kfar Saba

Teva, Texas strike opioid settlement worth $225 million

Teva Pharmaceutical Industries Ltd was facing claims that they fueled an opioid epidemic in Texas by improperly marketing addictive pain medications.

 Teva building in Kfar Saba

Drugmaker Teva fueled opioid addiction in New York, jury finds

New York and Nassau and Suffolk counties had accused the Israel-based drugmaker of engaging in misleading marketing practices that fueled opioid addiction in the state.

 Teva building in Kfar Saba

California judge rules for Israeli Teva in major opioid lawsuit

The lawsuit was originally filed in April, when several California counties accused drugmakers of fueling America's opioid crisis.

An Israeli flag flutters near the logo of Teva Tech which is part of Teva Pharmaceutical Industries in Neot Hovav, southern Israel December 14, 2017.

Israeli team says AI platform can predict which drugs are safe, effective

Quris, an artificial intelligence (AI) company operating in the pharmaceutical space, launched this week and announced a $9 million in seed funding.

 Chips from Quris' AI technology.